Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-12

Clinical Trial Update: Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study [Phase 2]

View source ↗

Summary

Phase 2 feasibility study evaluating psilocybin for alcohol use disorder; status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Anders Fink-Jensen, MD, DMSci | Conditions: Alcohol Use Disorder (AUD) | Phase 2 | Status: ACTIVE_NOT_RECRUITING